NIPER Mohali Partners with Novartis to Advance Industry–Academia Collaboration

Date:

Share post:

By Dose Daily News Bureau

20th April, 2026

19:00 PM IST

The National Institute of Pharmaceutical Education and Research (NIPER) Mohali, has signed a formal collaboration agreement with Novartis Healthcare Private Limited, marking a significant step towards strengthening industry academic ties in pharmaceutical research. The agreement was signed in the presence of Manoj Joshi, Secretary, Department of Pharmaceuticals, who stretched the importance of moving such partnerships from pilot stages to scalable impact driven initiatives that addresses genuine healthcare needs.

The partnership brings all 7 NIPER institutes into a unified framework aligned with India’s broader pharmaceutical innovation goals. On 15th April 2026, faculty members collectively submitted 42 research proposals for consideration. Following a rigorous evaluation process one proposal earned the prestigious Development Pioneer grant, recognizing its potential for real-world application and scientific merit.

The initiative is designed to ensure academic research remains application-driven and grounded in clinical relevance, fostering the next generation of pharmaceutical innovators. The signing ceremony was attended by key stakeholders including Avadhesh Kumar Chaudhary, Kini Singh, Dulal Panda, and senior leadership from Novartis.

Written by: Pragna Biswas

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related articles

Bhawanipur Global Campus Announces iNATCONPH 2026: A Global Platform for Pharmacy & Allied Health Research

Kolkata: Bhawanipur Global Campus has announced the 16th International Conference - iNATCONPH 2026, a prestigious international scientific conference...

Emcure Pharma Receives CDSCO Approval to Launch Poviztra®️ for Fatty Liver Disease Treatment

Emcure Pharmaceuticals Ltd  announced that its co-marketed semaglutide brand, Poviztra®, has received regulatory approval from the Central Drugs...

CDSCO Partners with THSTI to Strengthen Vaccine and Healthcare innovation

The Central Drugs Standard Control Organization (CDSCO), India’s national regulatory authority, and the Translational Health Science and Technology...

EMeRG Launches Hospital Intel Suite™️ to transform MedTech Market

EMeRG, a leading healthcare intelligence provider with over a decade of industry expertise,  announced the launch of Hospital...